Momelotinib receives FDA approval for patients of myelofibrosis with anaemia Dr. Kamal Kant Kohli19 Sept 2023 8:00 PM ISTUSA: JAK inhibitor momelotinib (Ojjaara) has received approval from the US Food and Drug Administration (FDA) as the first therapy specifically for...
Blood test may lower risk of disability in children with MS: Lancet Dr. Kamal Kant Kohli17 Sept 2023 8:00 PM ISTUSA: A recent study published in The Lancet Neurology has revealed that an experimental method developed to detect nerve injury in multiple sclerosis...
FDA approves generic version of estradiol gel for moderate to severe vasomotor symptoms due to menopause Dr. Kamal Kant Kohli29 Aug 2023 11:30 AM ISTThe US Food and Drug Administration has approved generic version of estradiol gel Divigel for moderate to severe vasomotor symptoms during ...
Tyruko, first biosimilar received FDA approval for treating multiple sclerosis Dr. Kamal Kant Kohli26 Aug 2023 10:30 AM ISTUSA: The US Food and Drug Administration (FDA) has approved the first biosimilar for treating multiple sclerosis.The approval was given to Tyruko...
FDA panel backs ultrasound-based renal denervation system for uncontrolled hypertension Dr. Kamal Kant Kohli25 Aug 2023 9:45 AM ISTUSA: An ultrasound renal denervation system has got backing from an FDA panel as a possible treatment for hypertension.The FDA's Circulatory System...
Valbenazine receives FDA approval for chorea associated with Huntington's disease Dr. Kamal Kant Kohli23 Aug 2023 11:15 AM ISTUSA: The US Food and Drug Administration has expanded the label for valbenazine (Ingrezza) capsules to include chorea associated with Huntington's...
First Vaccine for Pregnant Individuals to Prevent RSV in Infants approved by FDA Dr. Kamal Kant Kohli22 Aug 2023 12:00 PM ISTRespiratory Syncytial Virus is a highly contagious virus that causes respiratory infections in individuals of all age groups. Furthermore it is the...
FDA approved antipsychotic brexpiprazole shows no meaningful benefit, may raise mortality risk: finds study Dr. Kamal Kant Kohli22 Aug 2023 11:45 AM ISTUSA: The US Food and Drug Administration (FDA) has fast-tracked the approval of the antipsychotic drug brexpiprazole (Rexulti) despite its failure to...
FDA approves pozelimab as first treatment for adults and children with CHAPLE disease Dr. Kamal Kant Kohli21 Aug 2023 11:30 AM ISTThe US Food and Drug Administration has approved pozelimab (Veopoz)as the first treatment for adults and children ages 1 year and up CHAPLE disease. ...
FDA approves palovarotene for treatment of rare bone disorder Dr. Kamal Kant Kohli17 Aug 2023 9:45 AM ISTThe US Food and Drug Administration has approved oral retinoid palovarotene (Sohonos) for treatment of abnormal bone growth associated with...
FDA accepts new antibiotic combo for priority review for complicated UTI Dr. Kamal Kant Kohli16 Aug 2023 11:30 AM ISTThe US Food and Drug Administration (FDA) has accepted cefepime-taniborbactam antibiotic combination for priority review for treatment of complicated...
FDA approves niraparib regimen for BRCA-mutated metastatic castration-resistant prostate cancer Dr. Kamal Kant Kohli12 Aug 2023 10:15 AM ISTThe Food and Drug Administration has approved the fixed dose combination of niraparib and abiraterone acetate (Akeega, Janssen Biotech, Inc.), with...
